[ET Net News Agency, 8 December 2025] REMEGEN (09995) fell 10.7% to HK$78.9.
It hits an intra-day low of HK$78.9, dipping below the 100-D SMA of HK$87.846, and an
intra-day high of HK$89.25. The total shares traded was 4.19 million, with a value of
HK$342.91m. The active buy/sell ratio is 30:70, with net selling turnover of HK$134.29m.
CHINA INV INFO accounts for greatest net responsive buying turnover of HK$59.88m, with
volume weighted average price of HK$81.854. J.P. MORGAN BRO (HK) accounts for greatest net
responsive selling turnover of HK$20.81m, with volume weighted average price of HK$81.718.
The stock has fallen a combined 12% over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 78.900 % Chg -10.70%
High 89.250 Low 78.900
Shares Tr 4.19m Turnover 342.91m
10-D SMA 86.495 %H.V 53.128
20-D SMA 84.902 VWAP 81.841
50-D SMA 92.233 RSI14 40.686
----------------------------------
Status: Dipping below the 100-D SMA, active buy/sell ratio is 30:70, with net selling
turnover of HK$134.29m, falling a combined 12% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
----------------------------------------------
REMEGEN (09995) 78.90 -10.70
SINO BIOPHARM (01177) 6.82 -0.29
HENGRUI PHARMA (01276) 73.90 +0.27
3SBIO (01530) 29.16 -1.42
EVEREST MED (01952) 44.32 -2.38
KEYMED BIO-B (02162) 58.20 -1.52
SKB BIO-B (06990) 436.40 -5.13
DUALITYBIO-B (09606) 327.20 -2.62
ZAI LAB (09688) 15.35 -1.67
AKESO (09926) 123.70 -0.32
----------------------------------------------
(ed)